Browse News
Filter News
Found 534,950 articles
-
Ahead of being absorbed by Bristol-Myers Squibb, Celgene forged a strategic collaboration with two companies to develop immuno-oncology treatments and cell therapies.
-
Eli Lilly’s ANNOUNCE Phase III clinical trial of Lartruvo (olaratumab) in advanced or metastatic soft tissue sarcoma failed to meet the primary endpoints of overall survival.
-
BioSpace Movers and Shakers: Jan. 18
1/18/2019
Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more. -
Yesterday, the Endocrinologic and Metabolic Drugs Advisory Committee had a split vote, 8 to 8, on whether the overall benefits of Zynquista (sotagliflozin) outweiged the risk in order to support approval. This sends things back to the agency to make a final decision, which has a target action dat...
-
Immunomedics was hoping for a green light from the U.S. Food and Drug Administration for its triple-negative breast cancer treatment, sacituzumab govitecan. However, this morning the company announced that approval will not likely be coming any time soon.
-
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
-
The two companies inked a non-disclosure agreement on December 22, 2018 and amended it a day later. One of the things apparent is that the companies wanted to make a splash at the JPM conference.
-
Janssen Pharmaceuticals and Apple have teamed up to determine if a new app for the Apple Watch, which has a built-in electrocardiogram can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating compl...
-
January 18 Research Roundup: Skin Cancer, Turning Cancer Cells Into Fat Cells, and a Longevity Test
1/18/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Novartis and Oxford will use artificial intelligence and advanced analytics to identify early predictors of inflammatory diseases.
-
Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression
1/18/2019
Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, reported new findings identifying a potential association between CXCL12 expression and clinical benefit in patients with pancreatic cancer treated with tipifarnib.
-
Invitrocue roll-out of Onco-PDOTM services in Germany
1/18/2019
Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the signing of its first laboratory agreement in Germany as part of its strategy to make its Onco-PDOTM personalised cancer screening service available to patients and physicians in Germany.
-
Neurovascular Embolization Devices Market is expected to account for more than US$ 1,733.1 Mn, in terms of value, by 2028 end
1/18/2019
The increasing awareness regarding neurovascular disease, and technological advancements in the diagnostic techniques are expected to propel the demand for neurovascular embolization devices over the forecast period.
-
Cannabis Company Starling Brands, Inc. Announces Global Licensing Partnership with Pioneering CBD Brand, Jayden's Juice
1/18/2019
Starling Brands is pleased to announce the expansion of their global licensing, manufacturing and distribution deal with world-renowned brand Jayden's Juice, one of the pioneers in the cannabis CBD movement.
-
Photo of Cigna Building Blessings in a Backpack in Phoenix Available on Business Wire's Website and the Associated Press Photo Network
1/18/2019
A photo is available on Business Wire's website and the Associated Press photo network of Cigna and Express Scripts employees at the Cigna Norterra office celebrating the combination of the two companies by filling 1,500 backpacks with food for children at the Nevitt Elementary School in Tempe, Arizona.
-
NJHA Installs Joseph W. Devine as Board Chair at 100th Annual Meeting
1/18/2019
Joseph W. Devine, FACHE, of Sewell, president of Jefferson Health New Jersey, today was installed as chair of the Board of the New Jersey Hospital Association, the state's oldest and largest hospital and healthcare advocacy organization.
-
CSTE approves Interim Position Statement for Nonfatal Opioid Overdose
1/18/2019
The Council of State and Territorial Epidemiologists (CSTE) has announced the approval of an interim position statement for nonfatal opioid overdose case definition for standardized public health surveillance
-
Michigan Teamster Appointed To Lead New Health Care Division, Women's Conference
1/18/2019
International Brotherhood of Teamsters General President Jim Hoffa has appointed Nina Bugbee as director of the newly created Teamsters Health Care Division and director of the Women's Conference.
-
Young Living Essential Oils Welcomes Wayne Moorehead as Executive Vice President of Marketing
1/18/2019
Young Living Essential Oils, the world leader in essential oils, announced today that it has hired Wayne Moorehead as Executive Vice President (EVP) of Marketing.
-
John Olajide Named Chair-Elect Of Dallas Regional Chamber
1/18/2019
John Olajide, founder and CEO of Axxess, the fastest-growing home healthcare technology company, has been selected by the Dallas Regional Chamber's Board of Directors as the organization's Chair for 2020.